Pharmacy Drugs
Recent Posts
- Democrats Push Medical Device Liability Bill
- FDA Investigates Heparin Link in Two Delaware Deaths
- Conflict Of Interest Reported In 29 Percent Of Cancer Studies
- Interim Results Of Abbott’s PROGRESS Study Show Rapid Viral Decline In Dual-Therapy Regimen Of Kaletra(R) (lopinavir/ritonavir) And Raltegravir
- Survival For Prostate Cancer Patients Younger Than 50 Improved By Surgery
Random Posts
- Orexo Announces Positive Phase III Results For KW-2246 In Japan
- Alzheimer's Prediction And Diagnosis May Be Improved By Brain Imaging And Proteins In Spinal Fluid
- Risk Of HIV Transmission Not Reduced By Herpes Medication
- Women Are At Greater Risk Than Men Of Graft Loss After Undergoing Liver Transplantation For Hepatitis C-related Liver Disease
- Can-Fite BioPharma To Initiate Phase I/II Clinical Trial With CF102 For The Treatment Of Hepatitis C Virus
- Excess Body Weight Causes Over 124,000 New Cancers A Year In Europe
- Sequel Systems Urges Hospital-Based And Managed Services Organizations To Adopt E-Prescribing Procedures
- Lethality Of H1N1 Influenza Virus Increasing According To Latest Analysis Of Virus Peptide Genomic Data
- Data From Enzo Therapeutics' Phase II Study Of Crohn's Disease Presented At Prestigious Gastroenterology Conference
- Stellar Pharmaceuticals Inc. Announces Watson Pharma, Inc. Has Received A Conditional IDE Approval For Stellar's Uracyst(R) From The FDA
Medtronic Issues Pacemaker Recall
Posted by: admin in Pharmacy Drugs on October 08th, 2009
LITTLE FALLS, N.J., June 12 — Certain pacemakers manufactured by Medtronic have been withdrawn from the market because of wiring problems, the FDA announced.
Of the more than 1.7 million Kappa and Sigma pacemakers implanted worldwide, about 21,300 are included in the recall.
They include devices in the Kappa Series 600/700/900 and Sigma Series 100/200/300 manufactured primarily between November 2000 and November 2002.
Patients can enter the serial number of their device at this Web site to find out whether it is included in the recall.
The FDA explained that the “devices may fail due to a separation of wires that connect the electronic circuit to other pacemaker components, such as the battery.”
In its letter to physicians, Medtronic estimated the failure rates of Kappa and Sigma pacemakers to be 1.1% and 4.8%, respectively.
In rare cases, patients who are pacemaker-dependent may experience serious injury or death resulting from the defect, the FDA said.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.